Hims & Hers rockets higher after Novo Nordisk to distribute weight-loss drugs on its platform
TL;DR Summary
Hims & Hers Health stock jumped about 40% after Novo Nordisk announced it would distribute weight-loss medications on the Hims & Hers platform, signaling a potential major partnership and upside for the telehealth company.
Topics:top-news#business#hims-and-hers#novo-nordisk#platform-distribution#stock-surge#weight-loss-drugs
- Hims & Hers stock surges as Novo Nordisk says it will distribute weight-loss drugs on platform Yahoo Finance
- Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs CNBC
- Hims & Hers Announces Strategic Shift for US Weight Loss Business HIMS Investor Relations
- Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration AP News
- Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers WSJ
Reading Insights
Total Reads
1
Unique Readers
10
Time Saved
82 min
vs 82 min read
Condensed
100%
16,389 → 34 words
Want the full story? Read the original article
Read on Yahoo Finance